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Abstract
Background: The prevalence of diseases other than tuberculosis (TB) detected during 
chest X- ray screening is poorly described in sub- Saharan Africa. Computer- assisted 
digital chest X- ray technology is available for TB screening and has the potential to be a 
screening tool for non- communicable diseases as well. Low- and middle- income coun-
tries are in a transition period where the burden of non- communicable diseases is in-
creasing, but health systems are mainly focused on addressing infectious diseases.
Methods: Participants were adults undergoing computer- assisted chest X- ray screen-
ing for tuberculosis in a community- wide tuberculosis prevalence survey in Blantyre, 
Malawi. Adults with abnormal radiographs by field radiographer interpretation were 
evaluated by a physician in a community- based clinic. X- ray classifications were com-
pared to classifications of a random sample of normal chest X- rays by radiographer in-
terpretation. Radiographic features were classified using WHO Integrated Management 
for Adult Illnesses (IMAI) guidelines. All radiographs taken at the screening tent were 
analysed by the Qure.ai qXR v2.0 software.
Results: 5% (648/13,490) of adults who underwent chest radiography were identified 
to have an abnormal chest X- ray by the radiographer. 387 (59.7%) of the participants 
attended the X- ray clinic, and another 387 randomly sampled normal X- rays were avail-
able for comparison. Participants who were referred to the community clinic had a sig-
nificantly higher HIV prevalence than those who had been identified to have a normal 
CXR by the field radiographer (90 [23.3%] vs. 43 [11.1%] p- value < 0.001). The com-
monest radiographic finding was cardiomegaly (20.7%, 95% CI 18.0– 23.7). One in five 
(81/387) chest X- rays were misclassified by the radiographer. The overall mean Qure.
ai qXR v2.0 score for all reviewed X- rays was 0.23 (SD 0.20). There was a high concord-
ance of cardiomegaly classification between the physician and the computer- assisted 
software (109/118, 92.4%).
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I N TRODUC TION
As of 2019, tuberculosis (TB) was the single leading infec-
tious cause of mortality in the world [1]. Globally, there were 
about 132 (118– 146) new TB cases per 100,000 population 
in 2018 [1]. A considerable number of TB cases go undiag-
nosed [2], driving the need for alternative measures to ac-
tively identify new cases of TB in communities in the hopes 
of meeting the targets for the End- TB Strategy [1,3].
There is a growing interest in the automated analysis of 
chest X- rays (CXR) as a sensitive and inexpensive means 
of screening populations for tuberculosis [4]. Computer- 
assisted digital chest X- ray (CADXR) displays high sensi-
tivity for the identification of features of TB but is not well 
calibrated for identifying non- TB X- ray abnormalities [5]. 
Additionally, non- TB X- ray abnormalities have not been well 
characterised in the sub- Saharan African setting [4].
The pattern of diseases in low- and middle- income coun-
tries is shifting from predominantly communicable diseases 
to the emergence of non- communicable diseases (NCDs) 
[6- 8]. Yet, the focus still remains on mainly combatting in-
fectious diseases, leaving an unmet need for interventions 
focused on NCDs [9]. NCDs account for nearly 70% of deaths 
worldwide, with an estimated 75% of these deaths occurring 
in low- and middle- income countries [10]. There is, however, 
a paucity of data on the true burden of non- communicable 
diseases in low- income countries [11].
There is a rising prevalence of NCDs identified in health 
facilities [12], displaying a need for community- level atten-
tion to these diseases. Malawi has a high prevalence of HIV 
and TB [1]. Multiple studies affirm the association of these 
infectious diseases with certain NCDs, especially diabetes 
mellitus, hypertension and chronic obstructive pulmonary 
disease (COPD) [13- 15].  These NCDs, though a result of 
multiple risk factors, have a higher risk of development in 
people living with HIV (PLHIV) than in the general popu-
lation [9,16,17]. Near universal access to HIV antiretroviral 
therapy (ART) is leading to an increasing number of age-
ing adults living with HIV allowing for the emergence of 
chronic sequelae, such as cardiovascular diseases, chronic 
lung diseases and diabetes [18- 20].
We report on the activities of an urban community clinic 
located within a TB prevalence survey using CADXR con-
ducted in high- density settlements in Blantyre District, 
Malawi. The main aims of this study were to describe the 
abnormalities that reflect an abnormal chest X- ray during 
a community- wide prevalence survey for tuberculosis that 
included screening using chest radiography, as well as to 
compare the classification of X- rays by the radiographer, 
physician and the Qure.ai qXR v2.0 software. Additionally, 
we described the prevalence of communicable and non- 
communicable diseases in adult community members based 
on syndromic diagnoses by the physician.
M ETHODS
Design
This was a cross- sectional study of adults (≥ 18 years) iden-
tified during a TB prevalence survey for the SCALE Trial 
(Registration Number: ISRCTN11400592), which investigated 
the effect of community- wide active door- to- door screening 
for tuberculosis. The prevalence survey was conducted be-
tween 26 May 2019 and 31 March 2020 in 72 clusters.
Study population
The study was implemented in the geographically defined 
catchment population of 315 community health work-
ers (CHW) in the high- density and peri- urban residential 
areas of Blantyre City. CHW catchment areas were grouped 
to form 72  clusters with a population of about 4400 adult 
residents each (approximately 320,000 adults total). CHW 
catchment areas and study population were defined by a 
city- wide enumeration survey conducted together with the 
Blantyre District Health Office (DHO) in 2015 [2].
Participants of the prevalence survey were adults (18 years 
and older) from randomly selected households from the de-
fined CHW catchment areas. Participants had to provide 
informed consent, be willing to undergo radiological screen-
ing for TB, and intend to remain resident within Blantyre 
City for at least the subsequent eight weeks.
Study procedures
Resident adults (≥ 18 years) were recruited at their house-
holds. After the informed consenting process, participants 
were screened using symptom screening (cough, fever, 
night sweats or weight loss) and those with a cough were 
asked to submit spot sputum samples. All interviewed par-
ticipants were then referred to a screening tent within the 
community, where they had digital chest radiography and 
Conclusion: There is a high burden of cardiomegaly on a chest X- ray at a community 
level, much of which is in patients with diabetes, heart disease and high blood pressure. 
Cardiomegaly on chest X- ray may be a potential tool for screening for cardiovascular 
NCDs at the primary care level as well as in the community.
K E Y W O R D S
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were offered HIV testing and counselling. HIV testing was 
offered using OraQuick HIV- 1/2 and parallel finger- prick 
Alere (Abbott) Determine™ HIV- 1/2. A positive HIV test 
result was confirmed using Trinity Biotech Uni- Gold™. All 
those with a chest X- ray classed as abnormal by onsite ra-
diographers were asked to submit sputum. Sputum samples 
were sent to the laboratory for microscopy, Xpert MTB/Rif 
and culture.
Participants with abnormal chest radiographs after as-
sessment by a radiographer were given a referral card and 
referred to a community- based tent clinic in the same cluster 
for further evaluation by a physician. Radiographers were ra-
diology technicians with diploma- level training (two years) 
in radiology and study- specific training on radiological fea-
tures of TB. The radiographers reviewed the radiographs for 
any identifiable abnormality (including features not sugges-
tive of TB). All radiographs taken at the screening tent were 
analysed by Qure.ai qXR v2.0 software. The field radiogra-
phers referred patients to the tent clinic independent of the 
Qure.ai qXR v2.0 report.
The study clinic tent was mounted the week following 
the departure of the screening team from the community 
location. The tent clinic was held on one day for each of the 
72 clusters in the prevalence survey. The clinic field worker 
contacted the participants using cellular phone contacts to 
remind them to attend the clinic. Participants attending the 
clinic were first evaluated by a nurse who recorded vital signs 
including blood pressure, resting heart rate, respiratory rate 
and oxygen saturation using a pulse oximeter.
The physician conducted a history and a focused physical 
examination. Paper- based forms were used to collect clini-
cal data at the X- ray clinic and were stored in a locked cabi-
net. Variables that were collected included age, sex, smoking 
and alcohol history, TB history, HIV status, ART history (if 
HIV- positive), cough, fever, night sweats, weight loss, history 
of any chronic non- communicable diseases and any other 
symptoms.
The tent- based clinic was equipped with medications 
that allowed the management of simple infectious and non- 
infectious diseases, including amoxicillin, cotrimoxazole, 
doxycycline, metronidazole, paracetamol, ibuprofen, mag-
nesium trisilicate, omeprazole, prednisolone, salbutamol in-
halers, hydrocortisone 1% cream and clotrimazole 1% cream. 
All other diagnoses that required management were referred 
either to a primary care facility or to a tertiary centre.
Definitions
X- ray images of participants were reviewed on a laptop com-
puter equipped with Microdicom DICOM Viewer (version 
3.3.2). Physician classifications were done independently 
of Qure.ai qXR v2.0 reports. X- ray features were classified 
using the WHO Integrated Management of Adult Illnesses 
(IMAI) guidelines, designed for use in primary healthcare 
facilities, which include guidelines for classifying chest X- 
rays [21]. The classifications are as follows: ‘normal’, ‘possible 
TB’, ‘old TB’, ‘pleural effusion’, ‘pneumonia’, ‘cardiomegaly’ 
and ‘chronic obstructive airways disease (COAD)’.
Qure.ai qXR v2.0 (http://qure.ai/qxr/) analyses the un-
obscured lung fields of a posteroanterior chest X- ray for the 
presence of abnormalities and outputs a TB score of between 
0 and 1 [22]. Convolutional neural networks were trained 
to identify 10 individual CXR abnormalities, which include 
blunting of costophrenic angles, nodules, cardiomegaly, cav-
itary lesions, consolidation, fibrosis, emphysema, hilar en-
largement, opacities and pleural effusions.
The Qure.ai qXR v2.0 reports the TB scores and sum-
marises the chest X- ray by the following categorisations: 
‘high- risk TB screening (HRTBS)’, ‘routine TB screening 
(RTBS)’, ‘abnormal’ and ‘no significant abnormality’. The 
Qure.ai qXR v2.0  software assigns a score of at least 0.45 
for X- rays with features of TB, which include cavitating le-
sions, nodules, fibrosis, consolidation and pleural effusions, 
which may be classified as diagnoses other than active TB 
by the human reader. The software summarises as abnormal 
all features that are not suggestive of TB, along with X- ray 
features that do not fit within the spectrum of the classifica-
tions allowed by the software.
We used the predefined classifications for TB likelihood 
provided by the software report (HRTBS and RTBS). The 
classification of ‘no significant abnormality’ was transcribed 
as ‘normal’. Cardiomegaly as a feature was recorded on its 
own, thus leaving the classification ‘abnormal’ to be used 
only for X- ray features that do not fit within the spectrum of 
the classifications allowed by the software.
Chronic obstructive airways disease on X- ray was defined 
as the presence of hyperexpanded hazy lungs, flattened di-
aphragm or increased broncho- vascular markings on chest 
X- ray. High blood pressure was defined as at least two read-
ings with a systolic value of >140 mmHg and/or a diastolic 
value of >85 mmHg. Patients with a pre- existing diagnosis 
of asthma or a history and chest X- ray suggestive of lung 
disease due to previous TB or chronic obstructive airways 
disease were summarised as chronic lung diseases. Patients 
with a pre- existing diagnosis of diabetes were classified as 
having diabetes as the tent clinic was not equipped to screen 
for and diagnose new cases of diabetes. Patients with a his-
tory that was strongly suggestive of diabetes were classified 
as ‘possible diabetes’. Patients with a pre- existing diagnosis 
of heart disease, or a history and examination strongly sug-
gestive of a heart pathology with or without chest X- ray ab-
normalities were classified as ‘heart disease’. All pathologies 
were defined syndromically based on history and examina-
tion [23,24], with support from the chest radiograph where 
appropriate (Table S1). Bacteriologically confirmed TB was 
defined as at least one positive laboratory investigation 
(smear microscopy, Xpert MTB/RIF or culture).
Statistical analysis
The primary study outcome was to define the prevalence 
of pathologies causing abnormal chest radiography at TB 
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screening, disaggregated into communicable and non- 
communicable diseases causes. The secondary outcome was 
to compare X- ray classifications by the radiographers, physi-
cian and Qure.ai qXR v2.0 software.
A random sample of 387 prevalence survey participants 
classified as normal by the radiographer was selected from 
the main SCALE prevalence survey database using Stata 
(version 14.2) (Statacorp. 2015. Stata Statistical Software: 
Release 14. College Station, TX: StataCorp LP). The classifi-
cation of X- rays by the physician was used as the reference as 
this reflects the best- case scenario in primary and secondary 
care facilities in Blantyre and was compared to the radiogra-
pher and the computer- aided classifications.
Statistical analyses were performed using R (version 
4.0.0), 2020 (Vienna, Austria: R Foundation for Statistical 
Computing), and Stata. Participant distribution was described 
using mean and standard deviation (SD) for numerical data 
and proportions for categorical data. Baseline characteristics 
were compared between those who were identified to have an 
abnormal versus a normal chest X- ray by the field radiogra-
pher using Chi- square tests and Fisher's exact tests.
R E SU LTS
Tracing of participants
Of the 15,897 participants in the prevalence survey, 13,490 
(84.9%) underwent a CXR – Figure 1. Of these 13,490, 648 
(4.8%) participants were identified to have an abnormal 
chest X- ray by the field radiographer and were referred to 
the community- based X- ray clinic for evaluation by a physi-
cian. Of the booked participants, 261 (40.3%) did not attend 
the clinic leaving 387 (59.7%) participants who attended and 
were reviewed by a physician. A 1:1 random sample of 387 
prevalence survey participants who were classified as nor-
mal by the field radiographer were selected for X- ray clas-
sification by the physician and computer- assisted algorithm 
and compared with the clinic attendees.
Baseline characteristics
Table 1 describes the baseline characteristics of the partici-
pants of the tent clinic. A total of 774 X- rays were reviewed by 
the physician and the Qure.ai qXR v2.0 automated system. 
The median age of the participants was 37 (IQR 25.0– 50.0), 
with participants referred with an abnormal X- ray being sig-
nificantly older than those with normal X- rays (median age 
43 [IQR 32.5– 58.5] vs. 28 [IQR 22.0– 40.0], respectively). The 
overall proportion of women was 62.0% (480/720), with no 
difference in gender distribution between the two groups.
Participants with abnormal CXRs by the field radiog-
rapher interpretation had poorer self- reported health than 
those with normal X- rays (76/387 [19.7%] vs. 19/387 [4.9%], 
respectively). A larger proportion of those with an abnor-
mal X- ray compared to those with a normal X- ray reported 
having at least one TB symptom (170/387 [43.9%] vs. 54/387 
[14.0%] p- value < 0.001). There was no significant differ-
ence in risk behaviour (smoking and alcohol consumption) 
between the groups (59/387 (15.3%) vs. 53/387 (13.7%) for 
smoking [p- value 0.540] and 10/387 (2.6%) vs. 14/387 (3.6%) 
for any amount of alcohol use [p value 0.407]).
About one in five of the participants declined HIV testing 
(160/774, 20.7%). This was significantly higher in those who 
were identified to have a normal chest X- ray by the field ra-
diographer than those who were referred to the X- ray clinic 
(109/387 [28.2%] vs. 51/387 [13.2%] p- value < 0.001). Overall, 
133/774 (17.2%) of the participants were HIV- positive, with 
only 8/774 (1.0%) being new positive diagnoses. The majority 
F I G U R E  1  Simplified study flowchart
Prevalence survey
participants (n=16,150)
Radiographer Abnormal
(n=743)
Radiographer Normal
(n=13,107)
Not selected
(n=12720)
Random sample
(n=387)
Physiscian assesment
(n=387)
Chest
radiography
Did not
attend
(n=356)
Computer-assisted interpretation
Referred to tent clinic
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T A B L E  1  Demographic characteristics of prevalence survey participants.
Characteristic Overall
Referred as radiographer 
abnormal
Sampled as radiographer 
normal p- value
Total 774 387 387
Female sex (%) 480 (62.0) 235 (60.7) 245 (63.3) 0.505
Median age, (IQR) 37.0 (25.0– 50.0) 43.0 (32.5– 58.5) 28.0 (22.0– 40.0) <0.001
Age group (%) <0.001
15– 24 185 (23.9) 42 (10.9) 143 (37.0)
25– 35 170 (22.0) 69 (17.8) 101 (26.1)
35– 44 173 (22.4) 94 (24.3) 79 (20.4)
45– 54 88 (11.4) 61 (15.8) 27 (7.0)
55– 65 75 (9.7) 59 (15.2) 16 (4.1)
>65 83 (10.7) 62 (16.0) 21 (5.4)
Literate (%) 690 (89.7) 334 (86.3) 356 (92.0) 0.015
Self- reported health status (%) <0.001
Very good 105 (13.6) 44 (11.4) 61 (15.8)
Good 482 (62.3) 211 (54.5) 271 (70.0)
Fair 92 (11.9) 56 (14.5) 36 (9.3)
Poor 76 (9.8) 61 (15.8) 15 (3.9)
Very poor 19 (2.5) 15 (3.9) 4 (1.0)
Previous or current TB (%) 65 (8.4) 51 (13.2) 14 (3.6) <0.001
Cough of any duration (%) 147 (19.0) 130 (33.6) 17 (4.4) <0.001
Night sweats (%) 80 (10.3) 63 (16.3) 17 (4.4) <0.001
Weight loss (%) 57 (7.4) 35 (9.0) 22 (5.7) 0.099
Fever (%) 57 (7.4) 45 (11.6) 12 (3.1) <0.001
TB symptom screen positive (%) 224 (28.9) 170 (43.9) 54 (14.0) <0.001
HIV test result (%) <0.001
Refused to test 160 (20.7) 51 (13.2) 109 (28.2)
Negative 481 (62.1) 246 (63.6) 235 (60.7)
Positive 133 (17.2) 90 (23.3) 43 (11.1)
New HIV 8 (1.0) 5 (1.3) 3 (0.8) <0.001
HIV- positive participants on ART 125/133 (94.0) 85/90 (94.4) 40/43 (93.0) 0.747
Proportion who have ever smoked 
(%)
112 (14.5) 59 (15.3) 53 (13.7) 0.540
Proportion who have ever consumed 
any alcohol (%)
24 (3.1) 10 (2.6) 14 (3.6) 0.407
Mid- upper arm circumference 
(MUAC) (mean (SD))
39.71 (27.15) 38.80 (26.76) 40.74 (27.77) 0.685
Bacteriologically confirmed TB 
(microscopy/Pert/ culture) (%)
11 (1.4) 11 (2.8) 0 (0.0) 0.002
Qure.ai qXR v2.0 (%) <0.001
Abnormal, consistent with TB 80 (10.3) 79 (20.4) 1 (0.3)
Abnormal, not consistent with TB 220 (28.4) 131 (33.9) 89 (23.0)
Normal 474 (61.2) 177 (45.7) 297 (76.7)
Physician reading (%) <0.001
Normal 490 (63.3) 184 (47.5) 306 (79.1)
Old TB 38 (4.9) 37 (9.6) 1 (0.3)
Other abnormalities 200 (25.8) 124 (32.0) 76 (19.6)
Possible TB 46 (5.9) 42 (10.9) 4 (1.0)
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of people with HIV were already on ART (125/133, 94.0%). 
Participants who were referred to the community clinic had 
a significantly higher HIV prevalence than those who had 
been identified to have a normal CXR by the field radiogra-
pher (90 [23.3%] versus 43 [11.1%] p- value < 0.001).
Abnormalities identified on chest X- ray
Cardiomegaly was the commonest abnormality identified 
on chest X- ray at 20.7% (95% CI 18.0– 23.7) of all chest X- rays 
reviewed (Table 2). The age distribution of the participants 
with cardiomegaly is shown in Figure 2. Cardiomegaly af-
fected all age groups involved in the survey. The propor-
tion of cardiomegaly increased with increasing age group. 
Cardiomegaly was significantly higher in participants with 
high blood pressure than those with normal blood pressure 
(54/90 [51.92%] vs. 36/90 [12.77%], p- value < 0.001). Other 
common X- ray abnormalities were features of chronic ob-
structive airways disease (5.2%, 95% CI 3.8– 7.0) and features 
of old TB (4.9%, 95% CI 3.6– 6.7).
One in five (81/387) chest X- rays were misclassified by 
the radiographer. Cardiomegaly (70/81 [86.4%]) was the 
commonest X- ray abnormality misidentified by the radiog-
rapher, followed by features of chronic obstructive airways 
disease (6/81 [7.4%]) – Table 2.
Physician diagnoses of clinic attendees based on 
physician assessment
Table 3 displays the diagnoses made by the physician at the 
community- based tent clinic. The commonest diagnosis 
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made among those attending the X- ray clinic was high blood 
pressure (104/304, [34.2%, 95% CI of 29.1– 39.7]). This was 
seconded by chronic lung diseases (CLD) with 69 (22.7%, 
95% CI of 18.3– 27.7) cases. Other common pathologies were 
musculoskeletal pathologies (7.6%, 95% CI of 5.1– 11.1), heart 
disease (6.9%, 95% CI of 4.6– 10.3) and gastritis (5.3%, 95% 
CI of 3.3– 8.4). About 70% (213/304) of diagnosed patholo-
gies had an abnormality on CXR. There was a high propor-
tion of cardiomegaly amongst patients with diabetes (66.7%, 
95% CI of 35.4– 87.9), heart disease (61.9%, 95% CI of 40.9– 
79.2) and high blood pressure (58.7%, 95% CI of 49.0– 67.6). 
Only 7.2% (95% CI of 3.1– 15.9) of patients with CLD had a 
normal CXR.
Qure.ai qXR v2.0 classification of X- rays
23.3% (90/387) of all X- rays classified as normal by the ra-
diographer were identified as abnormal by the automated 
system – Table 1. Table 4  shows the physician interpreta-
tion of the automated X- ray classifications. 38/387 X- rays 
were classified as HRTBS by the automated system, of whom 
50% (19/38) were classified as with old TB by the physician. 
The physician classification of cardiomegaly corresponded 
very closely with that of the computer (109/118, 92.4%). The 
software classification of abnormal was mainly classified as 
COAD (19/102, 18.6%) and cardiomegaly (16/102, 15.7%) by 
the physician.
The overall mean Qure.ai qXR v2.0 score for all reviewed 
X- rays was 0.23 (SD 0.20). Images classified as normal and 
abnormal by the physician scored 0.14 (SD 0.13) and 0.37 
(SD 0.23), respectively. The mean score of X- rays from con-
firmed TB patients was 0.62 (SD 0.34), while the mean score 
for patients with negative laboratory investigations was 0.22 
(SD 0.20). The highest mean Qure.ai qXR v2.0 score denoted 
features of active PTB (0.68, SD 0.21), followed by features 
suggestive of old TB (0.67, SD 0.19) – Figure 3.
DISCUSSION
This study describes the abnormalities found on CXR 
screening for TB at the community level. There was a high 
prevalence of non- tuberculous abnormalities described 
by a physician during this survey. The study also found a 
high burden of high blood pressure and cardiomegaly, a 
T A B L E  3  Diagnoses made at community- based tent clinic amongst clinic attendees (N = 387)
Diagnosisa 
Overall
N = 304
% (95% CI)
Cardiomegaly
N = 97
% (95% CI)
Other CXR abnormality 
N = 116
% (95% CI)
Normal CXR
N = 91
% (95% CI)
Chronic Lung Diseases (CLD) 69
22.7% (18.3– 27.7)
2/69
2.9% (0.8– 10.0)
62
89.9% (80.5– 95.0)
5
7.2% (3.1– 15.9)
Diabetes 9
3.0% (1.6– 5.5)
6/9
66.7% (35.4– 87.9)
0/9
0.0% (0.0– 30.0)
3/9
33.3% (12.1– 64.6)
Gastritis 16
5.3% (3.3– 8.4)
0/16
0.0% (0.0– 19.4)
2/16
12.5% (3.5– 36.0)
14/16
87.5% (64.0– 96.5)
Heart disease 21
6.9% (4.6– 10.3)
13/21
61.9% (40.9– 79.2)
0/21
0.0% (0.0– 15.5)
8/21
38.1% (20.8– 59.1)
High blood pressure 104
34.2% (29.1– 39.7)
61/104
58.7% (49.0– 67.6)
23/104
22.1% (15.2– 31.0)
20/104
19.2% (12.8– 27.8)
Malignancy 4
1.3% (0.5– 3.3)
1
25.0% (4.6– 69.9)
2
50.0% (15.0– 85.0)
1
25.0% (4.6– 69.9)
Musculoskeletal pathologies 23
7.6% (5.1– 11.1)
10
43.5% (25.6– 63.2)
3
13.0% (4.5– 32.1)
10
43.5% (25.6– 63.2)
Otherb 9
3.0% (1.6– 5.5)
0
0.0% (0.0– 29.9)
0
0.0% (0.0– 29.9)
9
100.0% (70.0– 100.0)
Suspected Pneumocystis 
jirovercii pneumonia
1
0.3% (0.1– 1.8)
0
0.0% (0.0– 79.3)
1
100.0% (20.7– 100.0)
0
0.0% (0.0– 79.3)
Pneumonia 17
5.6% (3.5– 8.8)
0
0.0% (0.0– 18.4)
17
100.0% (81.6– 100.0)
0
0.0% (0.0– 18.4)
Pulmonary TB 8
2.6% (1.3– 5.1)
1
12.5% (2.2– 47.1)
3
37.5% (13.7– 69.4)
4
50.0% (21.5– 78.5)
Extra- pulmonary TB 3
1.0% (0.3– 2.9)
0
0.0% (0.0– 56.1)
2
66.7% (20.8– 94.0)
1
33.3% (6.1– 79.2)
Upper Respiratory Tract 
Infections (URTI)
20
6.5% (4.3– 9.9)
3
15.0% (5.2– 36.0)
1
5.0% (0.9– 23.6)
16
80.0% (58.4– 91.9)
aNot unique summaries. Some participants had more than one pathology, while others had none.
bOther includes skin pathologies, hernias and prostatic disease.
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lower- than- expected prevalence of CXR abnormalities 
amongst those with the previous TB, and a high concord-
ance between the automated CXR and physician X- ray in-
terpretation. Cardiomegaly was found to be a prominent 
feature on chest radiography in cases of diabetes, heart dis-
ease and high blood pressure.
We found 160/774 (20.7%) participants with cardiomeg-
aly on chest X- ray screening in the community. This concurs 
with a similar study by Mungai et al., describing chest X- ray 
abnormalities in a community- wide TB prevalence survey 
[4]. Their studies found the prevalence of cardiomegaly on 
chest X- ray to be 23.1% (95% CI 20.6%– 25.6%) [4]. These are 
higher values than an earlier survey in South Africa, which 
found a prevalence of cardiomegaly on chest X- ray of 12.7% 
(95% CI 9.6%– 15.8%) [25].  The changing socio- economic 
paradigm and urbanisation may be implicated here, with 
more and more people being exposed to fast foods and sed-
entary lifestyles at home and work [6].
There remains a gap in the implications of cardiomegaly 
in otherwise healthy populations. Studies on cardiomeg-
aly in hospitalised populations suggest that it is a potential 
screening and triaging tool for cardiovascular disease in 
those patients [25,26]. A retrospective, descriptive study in 
Zambia suggested that 87.9% of cardiomegaly on chest X- ray 
had some cardiovascular abnormality on echocardiogram 
[27]. A systematic review done by Loomba et al included 
seven descriptive papers and found that cardiomegaly had a 
sensitivity of 83.3% and a specificity of 42.4% in the predic-
tion of an abnormal left ventricular end- diastolic dimension 
[28]. These studies support the utilisation of cardiomegaly 
on CXR as a triaging tool for cardiovascular disease in in- 
hospital populations and provide the basis for exploration of 
the potential role of cardiomegaly on CXR as a community- 
level screening tool for CVD.
The proportions of cardiomegaly on CXR in cases of di-
abetes, heart disease and high blood pressure were 66.7%, 
61.9% and 58.7%, respectively. These conditions are of pub-
lic health significance associated with premature mortality 
[25,29]. Studies are required to investigate the risks of pro-
gression of cardiomegaly found in these patient populations 
to heart disease and death, informing decisions on the use 
of cardiomegaly in screening and triaging algorithms for 
NCD care pathways in low- resource settings. Community- 
level interventions such as health messaging on the preven-
tion of NCDs may also be integrated into these screening 
programmes.
Based on the WHO IMAI classification, non- TB- related 
pulmonary abnormalities identified in this survey included 
features of COAD, pneumonia and effusions (9.4%, 68/774). 
Features of COAD alone accounted for 5.2% (40/774) of 
T A B L E  4  Comparison between physician X- ray classifications and qXR classifications (N = 774)
Computer- assisted 
classification
Physician WHO- IMAI X- ray classification
Overall Normal
Possible 
TB Cardiomegaly Old TB COAD
Pleural 
effusion Pneumonia
Normal 474 (62.2%) 431 (90.9%) 0 (0.0%) 31 (6.5%) 2 (0.4%) 9 (1.9%) 1 (0.2%) 0 (0.0%)
HRTBS 38 (4.9%) 0 (0.0%) 11 (28.9%) 1 (2.6%) 19 (50.0%) 3 (7.9%) 0 (0.0%) 4 (10.5%)
Cardiomegaly 118 (15.2%) 3 (2.5%) 0 (0.0%) 109 (92.4%) 0 (0.0%) 5 (4.2%) 1 (0.8%) 0 (0.0%)
RTBS 42 (5.4%) 11 (26.2%) 3 (7.1%) 3 (7.1%) 11 (26.2%) 4 (9.5%) 1 (2.4%) 9 (21.4%)
Abnormal 102 (13.1%) 45 (44.1%) 4 (3.9%) 16 (15.7%) 6 (5.9%) 19 (18.6%) 5 (4.9%) 7 (6.9%)
Abbreviations: HRTBS, High- risk TB screening; RTBS, Routine TB screening; COAD, Chronic obstructive airways disease; IMAI, Integrated management of adult illnesses.
F I G U R E  3  Qure.ai qXR v2.0 TB scoring for laboratory and radiological diagnoses. PTB, pulmonary tuberculosis
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the described non- TB chest X- ray anomalies. This is rela-
tively higher than the 3.2% (95% CI 2.3%– 4.4%) reported by 
Mungai et al. [4] Although chest X- ray has high interobserver 
variability [30], the high sensitivity for diagnosing features 
of emphysema [30,31] provides a potential for its application 
as a screening tool at the community level, informing deci-
sion for spirometry and other respiratory function tests.
Features of old TB accounted for 4.9% of all chest X- ray 
abnormalities. This would account for roughly 50% of all 
participants who had previous TB (38/65, 58.5% – Tables 
1 and 2). This value is much lower than in a South African 
and a Zimbabwean study, wherein 96% and 83% of the pa-
tients with post- TB CLD to had abnormal CXRs, respec-
tively [32,33]. A systematic review by Meghji et al. in 2016 
discovered a high prevalence of radiographic abnormalities 
in post- TB lung disease, the commonest of which was fi-
brosis (prevalence 25.0– 70.4%) [34]. This was higher still in 
post- multidrug- resistant TB cases [34]. These studies were 
all conducted in countries with higher socio- economic 
status than Malawi, included patients with the diagnosis 
of chronic lung disease secondary to the previous TB and 
did not fully describe interactions with other environmen-
tal confounders, such as air quality, smoking and mining. 
Inclusion of more sensitive tests such as CT scans may help 
define the true burden of radiographic abnormalities in pa-
tients who have had previous TB [4].
One in four (104/387, 26.9%) people were found to have 
high blood pressure on screening at the community- based 
tent clinic (referred by the radiographer as having an abnor-
mal chest X- ray). This is comparable to the projected pro-
portion of the population with raised blood pressure by the 
WHO in 2015 [35]. The 2009 Malawi National STEPS Survey 
demonstrated the overall prevalence of raised blood pressure 
in urban regions was 27.9% [36].
The prevalence of HIV in our study was 17.2% (133/774) 
with >90% ART coverage (94.0% of all PLHIV were on ART). 
According to the 2015– 2016 Malawi Population- based HIV 
Impact Assessment (MPHIA) report, the overall HIV prev-
alence among adults aged 15– 64 was 10.6% [37], a much 
lower proportion than we found in our study. However, 
disaggregated data demonstrate that the HIV prevalence in 
Blantyre City to be 17.1%, which is similar to what our study 
found [37].
Automated systems for CXR interpretation for the assess-
ment of TB are useful in this setting. Qure.ai qXR v2.0 gen-
erates a report with recommendations for TB screening and 
does not require the user to interpret a TB probability score 
[22]. Qure.ai qXR v2.0  has high sensitivity (93% to 98%) 
[22,38] and is tailored towards making recommendations 
for focused TB screening. The computer- assisted technology 
has been portrayed to be a tool for use in low- resource set-
tings where specialist opinion is lacking [38]. Qure.ai qXR 
v2.0 reporting system thus allows for a more harmonised 
approach to CXR classification, making it easier to create 
guidelines based on its performance. Our study found that 
50% of images that were recommended for HRTBS by the 
software had features of old TB by physician interpretation. 
Secondary- level testing using cartridge- based nucleic acid 
amplification tests (CBNAATs) such as Xpert MTB/RIF 
Ultra is still required to inform clinical decisions [39].
The automated diagnostics system has several potential 
areas where it can be applied. CADXR may have a role 
in outlining treatment algorithms, which assign patient 
groups to shorter treatment regimens, as evidenced by a 
review by Imperial et al. [40], which described adult pa-
tients with minimal TB disease (as defined by low smear 
grade or the absence of cavitation) as having a lower base-
line risk for unfavourable outcomes [40].  The CADXR 
system may also be used to track TB treatment progress 
[41]. Physicians can then use the CADXR system to re-
spond earlier to potential TB treatment failure, resulting 
in improved treatment outcomes. Further, the CADXR 
programme can be integrated into the Integrated Chronic 
Care community clinics that some districts in Malawi al-
ready have in plac. [42].
There are several limitations to our study. Due to the lim-
ited testing capacity at the tent, the true burden of infectious 
and non- communicable diseases could not be discerned. 
Additionally, the limited access to diagnostic tests meant the 
clinic physician had to rely on a syndromic approach to ar-
rive at most diagnoses, and thus, the range of diagnoses that 
could be made was narrow. There was a low referral turn 
up (52.1%) to the tent clinic, which could have introduced 
selection bias, and patients were not followed up to ascer-
tain reasons for failure to attend. Although all images from 
the study were posteroanterior radiographs, data were not 
collected on other X- ray quality factors. We did not have ac-
cess to radiologists in the study and had to use a physician 
for X- ray interpretation. The strength of the human X- ray 
interpretations may thus be low, but they do reflect the true 
picture of the health systems in the region.
CONCLUSION
There is a high burden of cardiomegaly on chest X- ray at 
the community level, especially in cases of diabetes, heart 
disease and high blood pressure. TB prevalence surveys that 
incorporate CXR screening of participants offer a platform 
for integrated screening of TB and cardiovascular NCDs in 
communities. There is also a need to propose resource spar-
ing interventions to strengthen primary prevention of car-
diovascular NCDs at primary care levels.
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